Progenity Announces Several Patents Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Ingestible Therapeutics Technologies
13 oct. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Oct. 13, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the United States Patent and Trademark Office (USPTO) has...
Progenity Announces Closing of $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
06 oct. 2021 16h02 HE
|
Progenity, Inc.
SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced registered...
Progenity Announces $20 Million Registered Direct Offering of Common Stock Priced at Premium to Market Under Nasdaq Rules
04 oct. 2021 13h40 HE
|
Progenity, Inc.
SAN DIEGO, Oct. 04, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced that it has entered into a definitive agreement with...
Progenity to Participate in 11th Annual Partnership Opportunities in Drug Delivery Conference
21 sept. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Sept. 21, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, announced today that the company will participate in the 11th annual Partnership...
Progenity to Participate in Two Upcoming Investor Conferences
03 sept. 2021 07h30 HE
|
Progenity, Inc.
SAN DIEGO, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in two upcoming virtual investor...
Progenity Announces Closing of $40 Million Underwritten Public Offering
24 août 2021 16h05 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 24, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the closing of its previously announced underwritten...
Progenity Announces Pricing of $40 Million Public Offering of Common Stock and Warrants
19 août 2021 22h20 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, today announced the pricing of its previously announced underwritten...
Progenity Announces Proposed Underwritten Public Offering of Common Stock and Warrants
19 août 2021 16h05 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 19, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (“Progenity”) (Nasdaq: PROG), an innovative biotechnology company, announced today that it intends to offer and sell, subject to market...
Progenity Provides Corporate Update and Reports Second Quarter 2021 Financial Results
12 août 2021 16h01 HE
|
Progenity, Inc.
Announced successful completion of the validation study PRO-104 for the Preecludia™ rule out test for preeclampsia and achievement of the primary endpoint of the study protocol Recently achieved...
Progenity to Report Second Quarter 2021 Financial Results and Provide Corporate Update
05 août 2021 16h05 HE
|
Progenity, Inc.
SAN DIEGO, Aug. 05, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (NASDAQ: PROG), an innovative biotechnology company, today announced that it will report second quarter 2021 financial results on...